Striatal dopamine D2, adenosine A2A and cannabinoid CB1 receptors balance as a target against non-cognitive symptoms in a mouse model of Alzheimer's disease
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/AAI Classification
InconclusiveFine-tuned Classification
N/ALarge-Scale Profiling of Coding and Long Noncoding Transcriptomes in the Hippocampus of Mice Acutely Exposed to Vaporized CBD or THC
Cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer’s disease through CB1 activation and inflammation modulation
Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis
CANNABIS NA GERIATRIA E GERONTOLOGIA: ALZHEIMER
Unraveling endocannabinoid signaling disruption in a preclinical model of neurodevelopmental disorders
Prenatal and early postnatal cannabis exposure interactions with adolescent chronic stress on anxiety-like, depression-like, and risk-taking behaviour